Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Population based screening - the difficulty of how to do more good than harm and how to achieve it
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1192542
Author(s) Zwahlen, M.; Low, N.; Borisch, B.; Egger, M.; Künzli, N.; Obrist, R.; Paccaud, F.; Zybach, U.; Probst-Hensch, N. M.
Author(s) at UniBasel Probst Hensch, Nicole
Künzli, Nino
Year 2010
Title Population based screening - the difficulty of how to do more good than harm and how to achieve it
Journal Swiss Medical Weekly
Volume 140
Pages / Article-Number 3-10
Abstract Screening people without symptoms of disease is an attractive idea. Screening allows early detection of disease or elevated risk of disease, and has the potential for improved treatment and reduction of mortality. The list of future screening opportunities is set to grow because of the refinement of screening techniques, the increasing frequency of degenerative and chronic diseases, and the steadily growing body of evidence on genetic predispositions for various diseases. But how should we decide on the diseases for which screening should be done and on recommendations for how it should be implemented? We use the example of prostate cancer and genetic screening to show the importance of considering screening as an ongoing population-based intervention with beneficial and harmful effects, and not simply the use of a test. Assessing whether screening should be recommended and implemented for any named disease is therefore a multi-dimensional task in health technology assessment. There are several countries that already use established processes and criteria to assess the appropriateness of screening. We argue that the Swiss healthcare system needs a nationwide screening commission mandated to conduct appropriate evidence-based evaluation of the impact of proposed screening interventions, to issue evidence-based recommendations, and to monitor the performance of screening programmes introduced. Without explicit processes there is a danger that beneficial screening programmes could be neglected and that ineffective, and potentially harmful, screening procedures could be introduced
Publisher EMH Schweizerischer Arzteverlag
ISSN/ISBN 1424-7860 ; 1424-3997
edoc-URL http://edoc.unibas.ch/dok/A5842986
Full Text on edoc Available
Digital Object Identifier DOI 10.4414/smw.2010.13061
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/20419512
ISI-Number WOS:000282844500001
Document type (ISI) Review
 
   

MCSS v5.8 PRO. 0.362 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
29/02/2024